These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 32000512

  • 21. 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging for the diagnosis of immune checkpoint inhibitor-associated myocarditis.
    Ederhy S, Devos P, Pinna B, Funck-Brentano E, Abbar B, Fenioux C, Cohen AA, Moslehi J, Bretagne M, Allenbach Y, Kharroubi D, Salem JE.
    Arch Cardiovasc Dis; 2022 Feb; 115(2):114-116. PubMed ID: 35120869
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Somatostatin Receptor Positron Emission Tomography/Computed Tomography in Giant Cell Myocarditis: A Promising Approach to Molecular Myocardial Inflammation Imaging.
    Polte CL, Bollano E, Oldfors A, Dudás A, Lagerstrand KM, Himmelman J, Bobbio E, Karason K, van Essen M, Bergh N.
    Circ Cardiovasc Imaging; 2022 Jan; 15(1):e013551. PubMed ID: 34961334
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Without Headache: Fever of Unknown Cause Due to Giant Cell Arteritis.
    Martinelli N, Marcolini L.
    J Clin Rheumatol; 2018 Jan; 24(1):38-39. PubMed ID: 28661925
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A giant mystery in giant cell myocarditis: navigating diagnosis, immunosuppression, and mechanical circulatory support.
    Fallon JM, Parker AM, Dunn SP, Kennedy JLW.
    ESC Heart Fail; 2020 Feb; 7(1):315-319. PubMed ID: 31872976
    [Abstract] [Full Text] [Related]

  • 28. How to prepare a patient for 18F-fluorodeoxyglucose positron emission tomography imaging to assess myocardial inflammation.
    Selvaraj S, Bravo PE.
    J Nucl Cardiol; 2024 Aug; 38():101888. PubMed ID: 38830570
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis.
    Yokoyama R, Miyagawa M, Okayama H, Inoue T, Miki H, Ogimoto A, Higaki J, Mochizuki T.
    Int J Cardiol; 2015 Sep 15; 195():180-7. PubMed ID: 26043154
    [Abstract] [Full Text] [Related]

  • 33. Demonstration of thyroidal metastasis from lung cancer by F-18 FDG PET scan.
    Jackson RT, Sinha P, Conrad GR.
    Clin Nucl Med; 2008 Jul 15; 33(7):505-6. PubMed ID: 18580244
    [Abstract] [Full Text] [Related]

  • 34. Mechanical assist and transplantation for treatment of giant cell myocarditis.
    Seeburger J, Doll N, Doll S, Borger MA, Mohr FW.
    Can J Cardiol; 2010 Feb 15; 26(2):96-7. PubMed ID: 20151055
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Is the endomyocardial biopsy in giant cell myocarditis of some help for the rapid indication for heart transplantation?
    Marzullo A, Serio G, Cazzato G, Capuzzolo M, Nardelli C, Salzillo C.
    Pathol Int; 2024 Feb 15; 74(2):96-98. PubMed ID: 38149499
    [No Abstract] [Full Text] [Related]

  • 37. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
    Rischpler C, Dirschinger RJ, Nekolla SG, Kossmann H, Nicolosi S, Hanus F, van Marwick S, Kunze KP, Meinicke A, Götze K, Kastrati A, Langwieser N, Ibrahim T, Nahrendorf M, Schwaiger M, Laugwitz KL.
    Circ Cardiovasc Imaging; 2016 Apr 15; 9(4):e004316. PubMed ID: 27056601
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP).
    Specht JM, Tam SL, Kurland BF, Gralow JR, Livingston RB, Linden HM, Ellis GK, Schubert EK, Dunnwald LK, Mankoff DA.
    Breast Cancer Res Treat; 2007 Sep 15; 105(1):87-94. PubMed ID: 17268819
    [Abstract] [Full Text] [Related]

  • 40. Complementary role of cardiac magnetic resonance imaging and 18F-FDG-positron emission tomography in myocarditis.
    Kafil TS, Bolen MA, Mountis M, Jellis CL, Jaber WA.
    Eur Heart J Cardiovasc Imaging; 2024 Jul 31; 25(8):e200. PubMed ID: 38489606
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.